Health and Human Services Secretary Alex Azar says the U.S. signed a contract with Pfizer for delivery in December of the first 100 million doses of a COVID-19 vaccine the pharmaceutical company is working to develop.
Health and Human Services Secretary Alex Azar speaks during a "National Dialogue on Safely Reopening America's Schools," event in the East Room of the White House, Tuesday, July 7, 2020, in Washington.
Pfizer Inc. and BioNTech SE announced separately that the agreement is with HHS and the Defense Department for a vaccine candidate the companies are developing jointly.The agreement is part of President Donald Trump’s Operation Warp Speed vaccine program, under which multiple COVID-19 vaccines are being developed simultaneously. The program aims to deliver 300 million doses of a safe and effective COVID-19 vaccine by January 2021, according to HHS.
Trump said Tuesday at a briefing that “the vaccines are coming, and they’re coming a lot sooner than anyone thought possible, by years.”
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Britain secures 90 million possible COVID-19 vaccine doses from Pfizer/BioNTech, ValnevaBritain has signed deals to secure 90 million doses of two possible COVID-19 vaccines from an alliance of Pfizer Inc and BioNTech , and French group Valneva , the business ministry said on Monday.
Weiterlesen »
Pfizer, BioNTech Get $1.95 Billion Covid-19 Vaccine Order From U.S. GovernmentPfizer and BioNTech said they have signed a $1.95 billion agreement with the U.S. Department of Health and Human Services and the Defense Department for millions of doses of a Covid-19 vaccine which Americans would receive for free.
Weiterlesen »
US government and Pfizer reach deal to produce millions of Covid-19 vaccine dosesThe US announces an agreement with Pfizer for the delivery of 100 million doses of a Covid-19 vaccine. The drugmaker still needs to complete a large Phase 3 clinical trial.
Weiterlesen »
Pfizer-BioNTech potential COVID-19 vaccine shows promise in additional dataGerman biotech firm BioNTech and U.S. drugmaker Pfizer on Monday reported additional data from their experimental COVID-19 vaccine that showed it was safe and induced an immune response in patients.
Weiterlesen »
U.S. to pay Pfizer, BioNTech $1.95 billion for millions of COVID-19 vaccine dosesPfizer Inc and German biotech firm BioNTech SE will get $1.95 billion from the U.S. government to produce and deliver 100 million doses of their COVID-19 vaccine candidate, the companies said on Wednesday.
Weiterlesen »
Uber offers COVID-19 contact tracing help amid chaotic U.S. responseUber has quietly launched a service to give public health officials quick access to data on drivers and riders presumed to have come into contact with someone infected with COVID-19, company officials told Reuters.
Weiterlesen »